查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198541

手術導航系統市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)

Surgical Navigation Systems Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

手術導航系統市場預計在預測期內的複合年增長率為 6.32%。

COVID-19 大流行對手術導航系統市場產生了重大影響，對擇期手術的區域限制導致一些手術被推遲。 此外，在 COVID-19 期間手術數量減少，阻礙了市場增長。 根據英國外科雜誌 2020 年報告，在 COVID-19 期間，約有 2800 萬次擇期手術被取消或推遲。 患者更願意等待看醫生，這影響了手術導航系統市場。 根據 2020 年 6 月發表的研究論文《COVID-19 對印度普通外科實踐的影響》，印度封鎖後的每日門診人數每天減少 4 人，約 77%。專家表示，他們沒有進行過一次手術手術。 另一方面，其他因素，例如對更好的患者治療效果和臨床試驗結果的需求，也可能推動新技術在導航輔助手術中的採用，並支持長期的市場增長。

手術導航系統是計算機輔助手術不可或缺的一部分。 它代表了一種支持基於數字成像技術的外科手術的概念。 這使得外科醫生能夠進行術前規劃，並在手術過程中對器械進行精確的手術導航。 骨關節炎、腦腫瘤和耳鼻喉科等目標疾病的患病率上升，以及人口老齡化加劇，可能是增長的驅動力。 根據 E-Clinical Medicine 2020 發表的一篇論文，膝骨關節炎 (OA) 的患病率在 15 歲及以上人群中為 16%，在 40 歲及以上人群中患病率為 22.9%。15 歲以上人群患病率為 20%年齡和 20% 的人超過 40 歲。 2020 年，全球約有 6.54 億人（40 歲及以上）患有膝關節炎。 對於 20 歲及以上的人，發病率為每 10,000 人年 203 例。 手術導航系統用於繪製患者膝蓋的地圖，以便更好地理解和有效地進行手術。 因此，預計對這項技術的需求會增加。

其他因素，例如對微創手術的需求不斷增長和技術進步，預計也將推動該市場的增長。 然而，手術導航系統價格昂貴，可能不會被一些醫院採用。

手術導航系統市場趨勢

心臟手術有望佔據較大的市場份額

心臟手術或心血管手術是由心臟外科醫生對心臟和大血管進行的手術。 在過去的幾年裡，技術在全球範圍內取得了長足的進步，手術導航系統在心血管手術中得到了廣泛應用。 心血管疾病發病率的增加和先進技術的可用性預計將推動這一領域的增長。

根據世界衛生組織 (WHO) 2021 年 6 月的統計數據，2019 年估計有 1790 萬人死於心血管疾病，佔全球所有死亡人數的 32%。 這些死亡中有 85% 是由於心髒病發作或中風。 據同一消息來源稱，2019 年有 1700 萬人（70 歲以下）過早死於非傳染性疾病，其中心血管疾病佔 38%。 因此，由於死亡率增加，心臟手術有望出現增長，從而推動該領域的增長。

然而，增加對心血管疾病治療的資助也有望促進創新和研究，從而促進市場增長。 根據美國國立衛生研究院 2020，預計 2022 年心血管疾病的投資預計為 26.22 億美元。 這比 2021 年的 24.99 億美元有了顯著增長。

產品發布、戰略合作夥伴關係和聯合協議預計將在預測期內推動這一細分市場。 例如，2020 年 11 月，雅培 (Abbott) 的新 EnSite X EP 系統在澳大利亞獲得了 CE 標誌和批准，並將在歐洲和澳大利亞推出該系統。 EnSite X 系統是唯一提供兩種不同選項的系統，可在一個平台上導航心肌解剖結構。

北美有望主導手術導航系統市場

北美在全球手術導航系統市場佔據主導地位，這主要是因為其成熟的醫療保健和醫療設備行業。 這種市場增長主要是由於手術導航系統市場上存在主要參與者。

在北美進行的手術數量不斷增加是市場增長的主要推動力。 例如，2021 年 1 月發表的一項題為“COVID-19 大流行對羅馬尼亞東北部三級護理中心胃腸內窺鏡檢查活動的影響”的研究發現，在 2019 年 COVID 之前，共有 3608 例內窺鏡檢查進行了大約每週 138 次手術。 這導致手術數量的增加，增加了對手術導航系統的需求並推動了市場的增長。

由於免疫系統減弱，老年人更容易患上慢性病。 根據《2019年世界老齡化報告》，2019年美國65歲及以上人口有5334萬人，預計到2050年這一數字將達到8481.3萬人。 老年人口的這種預期增加可能會增加慢性病的發病率，從而促進手術導航系統在診斷和治療中的使用。

亞太地區預計在預測期內增長最快，這主要是由於醫療行業越來越多地採用技術進步。

手術導航系統市場競爭者分析

世界主要參與者開發了大部分手術導航系統。 擁有更多研究資金和更好的分銷系統的市場領導者正在市場中站穩腳跟。 此外，由於意識的提高，亞太地區出現了一些較小的參與者，這有助於市場增長。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 慢性病的發病率和患病率增加
    • 豐富應用的技術進步
  • 市場製約因素
    • 手術導航系統成本高
    • 嚴格的產品審批規定
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按技術
    • 電磁感應法
    • 混合導航系統
    • 光學導航系統
    • 熒光 X 射線導航
    • CT導航
    • 其他技術
  • 通過申請
    • 神經外科
    • 骨科
    • 耳鼻喉手術
    • 心臟外科
    • 其他應用
  • 最終用戶
    • 醫院
    • 門診
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Brainlab AG
    • B Braun Melsungen AG
    • Fiagon AG
    • Karl Storz
    • Medtronic PLC
    • Siemens AG
    • Stryker Corporation（Scopis Gmbh）
    • Zimmer Biomet Holdings
    • Cascination AG
    • DePuy Synthes

第7章 市場機會今後動向

簡介目錄
Product Code: 67241

The surgical Navigation Systems Market is poised to witness a CAGR of 6.32% during the forecast period.

The COVID-19 pandemic has significantly impacted the surgical navigation system market, with regional restrictions on elective procedures causing several procedures to be delayed. Moreover, the number of surgeries declined during COVID-19, hampering the market growth. According to a British Journal of Surgery report 2020, approximately 28 million elective surgeries were canceled or postponed during COVID-19. Patients preferred to wait for hospital visits, which impacted the surgical navigation system market. According to the research article 'Impact of COVID-19 on General Surgical Practice in India,' published in June 2020, post-lockdown daily out-patient visits reduced to 4 patients/day in India, and approximately 77% of professionals did not perform even a single surgical procedure. ​​On the other hand, other factors, such as the demand for better patient outcomes and the results of clinical trials, are likely to drive the adoption of new technologies in navigation-assisted surgeries and support long-term market growth.

Surgical navigation systems are an integral part of computer-assisted surgery. This represents a concept that supports surgical procedures based on digital imaging technology. It allows surgeons pre-operative planning and accurate surgical navigation of instruments during the process. The growth is likely to be fueled by the rising prevalence of target conditions such as osteoarthritis, brain tumors, ENT disorders, and the growing senior population. According to the article published in the E-Clinical Medicine 2020, for people aged 15 and up, the prevalence of knee osteoarthritis (OA) was 16%, while in people aged 40 and above, the prevalence was 22.9%. In 2020, roughly 654 million people worldwide (40 years and older) had knee OA. In people aged 20 and above, the global incidence of knee OA was 203 per 10,000 person-years. Surgical navigation systems map the knee of the patient to understand it better and carry out efficient surgical operations. Hence, the demand for this technology is expected to increase.

Other factors like growing demand for minimally invasive procedures and technological advancements are also expected to drive the growth of this market. However, the high cost of surgical navigation systems may restrain some hospitals from adopting them.

Surgical Navigation Systems Market Trends

Cardiac Surgery Expected to have a Large Market Share

Cardiac surgery, or cardiovascular surgery, is surgery on the heart or great vessels performed by cardiac surgeons. The surgical navigation system is becoming more popular in cardiovascular surgery as technology has advanced significantly over the last few years worldwide. Factors such as the increasing occurrence of cardiovascular disorders and the availability of advanced technologies are expected to boost the segment's growth.

According to World Health Organization (WHO) Statistics for June 2021, an estimated 17.9 million people died from cardiovascular diseases in 2019, accounting for 32% of all global deaths. A heart attack or a stroke caused 85% of these deaths. According to the same source, non-communicable diseases were responsible for 17 million premature deaths (under 70) in 2019, with cardiovascular diseases accounting for 38% of these deaths. ​Hence, cardiac surgery is expected to witness growth due to the increased mortality rate, driving the segment growth.

However, the rise in funding for the treatment of cardiovascular disorders is also expected to boost innovation and research, leading to market growth. According to the National Institutes of Health 2020, the estimated investment for cardiovascular diseases was expected to be USD 2,622 million in 2022. This was a significant increase from the 2021 figures of USD 2,499 million.

The product launches, strategic partnerships, and collaborative agreements are expected to drive the segment over the forecast period. For instance, in November 2020, Abbott received CE Mark and approval in Australia for its new EnSite X EP System and is launching the system throughout Europe and Australia. The EnSite X System is the only system that offers the option to navigate the cardiac anatomy two different ways on one platform.

North America Expected to Dominate the Surgical Navigation Systems Market

North America dominates the global surgical navigation systems market, majorly attributed to the well-established healthcare and medical device industry. The market's growth is majorly due to the presence of key companies operating in the surgical navigation systems market.

The increase in the number of surgeries performed in North America is the major driving factor for market growth. For instance, as per the research study published in January 2021, titled "The Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy Activity in a Tertiary Care Center from Northeastern Romania", in 2019, during the pre-COVID time, a total of 3,608 endoscopic procedures were performed, which was about 138 procedures per week.​ This increases the number of surgeries, rising the demand for a surgical navigation system and driving the market growth.

The geriatric population is more prone to chronic diseases due to the weak immune system. According to World Ageing Report 2019, the United States had 53.340 million people aged 65 years and above in 2019, and this number is expected to reach 84.813 million by 2050. This expected increase in the elderly population is likely to increase the incidence rate of chronic diseases, thus driving the use of surgical navigation systems in diagnosis and treatment.

The Asia-Pacific region is believed to witness the fastest growth over the forecast period, mainly attributed to the increasing adoption of technological advancements in the healthcare industry.

Surgical Navigation Systems Market Competitor Analysis

The global key players are developing the majority of the surgical navigation systems. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness, which has helped the market grow.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Defination
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence and Prevalence of Chronic Disorders
    • 4.2.2 Technological Advancements Leading to Enhanced Applications
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Surgical Navigation Systems
    • 4.3.2 Stringent Regulations for Product Approval
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Technology
    • 5.1.1 Electromagnetic Navigation Systems
    • 5.1.2 Hybrid Navigation Systems
    • 5.1.3 Optical Navigation Systems
    • 5.1.4 Fluoroscopy-based Navigation Systems
    • 5.1.5 CT-based Navigation Systems
    • 5.1.6 Other Technologies
  • 5.2 By Application
    • 5.2.1 Neurosurgery
    • 5.2.2 Orthopedic Surgery
    • 5.2.3 ENT Surgery
    • 5.2.4 Cardiac Surgery
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Settings
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Brainlab AG
    • 6.1.2 B Braun Melsungen AG
    • 6.1.3 Fiagon AG
    • 6.1.4 Karl Storz
    • 6.1.5 Medtronic PLC
    • 6.1.6 Siemens AG
    • 6.1.7 Stryker Corporation (Scopis Gmbh)
    • 6.1.8 Zimmer Biomet Holdings
    • 6.1.9 Cascination AG
    • 6.1.10 DePuy Synthes

7 MARKET OPPORTUNITIES AND FUTURE TRENDS